US$ 29.76
glp 1 binge eating disorder Experts express alarm that GLP-1 RAs may trigger or worsen disorders. But is there any role they might play in eating disorder? And how can clinicians protect patients from risk? GLP-1 receptor agonists: A novel
Description
New Publication GLP-1 receptor agonists (GLP-1RAs), popular medications used for weight loss and the treatment of type 2 diabetes, have been increasingly prescribed in recent years, including to women of reproductive age

NAFLD is tightly associated with the global pandemic of obesity, metabolic syndrome (MS) and T2D, as well as with several genetic factors
It slows digestion, increases insulin release, and reduces glucose production in the liver, leading to better blood sugar control and potential weight loss

The cardiovascular protection begins shortly after starting treatment and persists long-term
Retatrutide, an experimental weight-loss drug, has not been approved by the FDA
